212 related articles for article (PubMed ID: 2004486)
1. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp 63).
Mendonça SC; Russell DG; Coutinho SG
Clin Exp Immunol; 1991 Mar; 83(3):472-8. PubMed ID: 2004486
[TBL] [Abstract][Full Text] [Related]
2. Does lipophosphoglycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins?
Mendonça SC; De-Luca PM; Olafson RW; Jardim A; Coutinho SG
Braz J Med Biol Res; 1994 Feb; 27(2):553-7. PubMed ID: 8081281
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T cell responses to purified leishmania antigens in subjects infected with Leishmania chagasi.
Vinhas V; Freire M; Bacellar O; Cunha S; Rocha H; Carvalho EM
Braz J Med Biol Res; 1994 May; 27(5):1199-205. PubMed ID: 8000341
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins.
Russo DM; Turco SJ; Burns JM; Reed SG
J Immunol; 1992 Jan; 148(1):202-7. PubMed ID: 1370169
[TBL] [Abstract][Full Text] [Related]
5. Activation of human T lymphocytes by Leishmania lipophosphoglycan.
Kemp M; Theander TG; Handman E; Hey AS; Kurtzhals JA; Hviid L; Sørensen AL; Were JO; Koech DK; Kharazmi A
Scand J Immunol; 1991 Feb; 33(2):219-24. PubMed ID: 1902000
[TBL] [Abstract][Full Text] [Related]
6. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
7. NKT cell activation by Leishmania mexicana LPG: Description of a novel pathway.
Zamora-Chimal J; Fernández-Figueroa EA; Ruiz-Remigio A; Wilkins-Rodríguez AA; Delgado-Domínguez J; Salaiza-Suazo N; Gutiérrez-Kobeh L; Becker I
Immunobiology; 2017 Feb; 222(2):454-462. PubMed ID: 27523746
[TBL] [Abstract][Full Text] [Related]
8. Antigen-reactive gamma delta T cells in human leishmaniasis.
Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
[TBL] [Abstract][Full Text] [Related]
9. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex.
Jardim A; Tolson DL; Turco SJ; Pearson TW; Olafson RW
J Immunol; 1991 Nov; 147(10):3538-44. PubMed ID: 1940354
[TBL] [Abstract][Full Text] [Related]
10. Distribution of lipophosphoglycan-associated epitopes in different Leishmania species and in African trypanosomes.
Tolson DL; Schnur LF; Jardim A; Pearson TW
Parasitol Res; 1994; 80(6):537-42. PubMed ID: 7528916
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
12. Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major.
Moll H; Mitchell GF; McConville MJ; Handman E
Infect Immun; 1989 Nov; 57(11):3349-56. PubMed ID: 2807527
[TBL] [Abstract][Full Text] [Related]
13. Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana.
Bahr V; Stierhof YD; Ilg T; Demar M; Quinten M; Overath P
Mol Biochem Parasitol; 1993 Mar; 58(1):107-21. PubMed ID: 8459823
[TBL] [Abstract][Full Text] [Related]
14. Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages.
Ibraim IC; de Assis RR; Pessoa NL; Campos MA; Melo MN; Turco SJ; Soares RP
Parasit Vectors; 2013 Mar; 6():54. PubMed ID: 23497381
[TBL] [Abstract][Full Text] [Related]
15. Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
Soto-Olguín N; Zamora-Chimal J; Delgado-Domínguez J; Becker I
Acta Parasitol; 2023 Mar; 68(1):122-129. PubMed ID: 36434381
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients.
Kurtzhals JA; Hey AS; Jardim A; Kemp M; Schaefer KU; Odera EO; Christensen CB; Githure JI; Olafson RW; Theander TG
Clin Exp Immunol; 1994 Jun; 96(3):416-21. PubMed ID: 8004810
[TBL] [Abstract][Full Text] [Related]
17. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 kilodalton glycoprotein, lipophosphoglycan and whole parasite antigens on the course of L. major infection in BALB/c mice.
Tonui WK; Mbati PA; Anjili CO; Orago AS; Turco SJ; Githure JI; Koech DK
East Afr Med J; 2001 Feb; 78(2):90-2. PubMed ID: 11682953
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to Leishmania mexicana promastigote antigens. I. Secreted acid phosphatase and other proteins share epitopes with lipophosphoglycan.
Ilg T; Menz B; Winter G; Russell DG; Etges R; Schell D; Overath P
J Cell Sci; 1991 May; 99 ( Pt 1)():175-80. PubMed ID: 1721919
[TBL] [Abstract][Full Text] [Related]
19. T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates.
Moll H; Röllinghoff M
Behring Inst Mitt; 1991 Feb; (88):161-9. PubMed ID: 2049034
[TBL] [Abstract][Full Text] [Related]
20. Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan.
Pinheiro RO; Pinto EF; de Matos Guedes HL; Filho OA; de Mattos KA; Saraiva EM; de Mendonça SC; Rossi-Bergmann B
Vaccine; 2007 Mar; 25(14):2716-22. PubMed ID: 16814903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
